- Home
- AQST vs URG Comparison
AQST vs URG Comparison
Compare AQST & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- URG
- Stock Information
- Founded
- AQST 2004
- URG 2004
- Country
- AQST United States
- URG United States
- Employees
- AQST N/A
- URG N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- URG Precious Metals
- Sector
- AQST Health Care
- URG Basic Materials
- Exchange
- AQST Nasdaq
- URG Nasdaq
- Market Cap
- AQST 390.4M
- URG 419.5M
- IPO Year
- AQST 2018
- URG N/A
- Fundamental
- Price
- AQST $3.96
- URG $1.22
- Analyst Decision
- AQST Strong Buy
- URG Strong Buy
- Analyst Count
- AQST 7
- URG 3
- Target Price
- AQST $11.29
- URG $2.63
- AVG Volume (30 Days)
- AQST 1.1M
- URG 5.4M
- Earning Date
- AQST 08-11-2025
- URG 08-12-2025
- Dividend Yield
- AQST N/A
- URG N/A
- EPS Growth
- AQST N/A
- URG N/A
- EPS
- AQST N/A
- URG N/A
- Revenue
- AQST $54,228,000.00
- URG $33,706,000.00
- Revenue This Year
- AQST N/A
- URG N/A
- Revenue Next Year
- AQST $51.62
- URG $224.22
- P/E Ratio
- AQST N/A
- URG N/A
- Revenue Growth
- AQST 5.29
- URG 200.09
- 52 Week Low
- AQST $2.12
- URG $0.55
- 52 Week High
- AQST $5.80
- URG $1.42
- Technical
- Relative Strength Index (RSI)
- AQST 50.64
- URG 51.27
- Support Level
- AQST $3.73
- URG $1.13
- Resistance Level
- AQST $4.10
- URG $1.42
- Average True Range (ATR)
- AQST 0.22
- URG 0.07
- MACD
- AQST -0.07
- URG -0.03
- Stochastic Oscillator
- AQST 17.42
- URG 31.03
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.